Clinical Trials

ASHP - Pharmacology and Clinical Trials

Assessment of Evidence for COVID-19-Related Treatments produced by the American Society of Health-System Pharmacists

University of Minnesota Randomized Clinical Trial

Post-exposure Prophylaxis or Preemptive Treatment for Coronavirus

"We are looking for participants who fit these criteria: 

  1. Exposed and WITHOUT symptoms

    • Closely exposed to a person with confirmed/test-proven COVID-19 disease within 4 days of enrolling, AND

    • Live in the same household as this person or are a healthcare worker, OR

  2. WITH symptoms

    • Currently diagnosed with confirmed/test-proven COVID-19 disease within 4 days of symptom onset, OR

    • Are a household contact or healthcare worker with a confirmed/test-proven COVID-19 contact, and are currently within the first 4 days of experiencing compatible symptoms with pending/unavailable testing

    • Not currently hospitalized

This study is only open to those within the United States." 

Mayo's Expanded Access to Convalescent Plasma for the Treatment of Patients With COVID-19

©2020 by Springfield/MU COVID-19.